Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2014

01-02-2014 | Letter to the Editor

Regression of conjunctival maltoma with topical antibiotics and steroids

Authors: Nikki Y. Far, Wing-yan Au, Chit Chow, Paul C. L. Choi, Kwok-Hung Chan, Alvin L. Young

Published in: Annals of Hematology | Issue 2/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS et al (2005) Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Nat Cancer Inst 97(18):1345–1353, Epub 2005/09/22PubMedCrossRef
2.
Au WY, Chan BC, Chung LP, Choy C (2003) Primary B-cell lymphoma and lymphoma-like lesions of the uterine cervix. Am J Hematol 73(3):176–179, Epub 2003/06/27PubMedCrossRef
3.
Yu CS, Chiu SI, Ng CS, Chan HH, Tse RK (2008) Localized conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma is amenable to local chemotherapy. Int Ophthalmol 28(1):51–54, Epub 2007/06/26PubMedCrossRef
4.
Perry A, Vincent BJ, Parker SR (2010) Intralesional corticosteroid therapy for primary cutaneous B-cell lymphoma. Br J Dermatol 163(1):223–225, Epub 2010/04/17PubMed
5.
Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW et al (2006) Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol: Off J Eur Soc Med Oncol/ESMO 17(1):135–140, Epub 2005/10/21CrossRef
6.
Graue GF, Finger PT, Maher E, Della Rocca D, Della Rocca R, Lelli GJ Jr, Milman T (2013) Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor. Eur J Ophthalmol. doi:10.​5301/​ejo.​5000224 PubMed
Metadata
Title
Regression of conjunctival maltoma with topical antibiotics and steroids
Authors
Nikki Y. Far
Wing-yan Au
Chit Chow
Paul C. L. Choi
Kwok-Hung Chan
Alvin L. Young
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1781-6

Other articles of this Issue 2/2014

Annals of Hematology 2/2014 Go to the issue

Letter to the Editor

Long-term response of refractory primary cold agglutinin disease to eculizumab therapy

Letter to the Editor

Paralyzed by a rare cause: an unusual case of metastatic diffuse large B cell lymphoma of the intramedullary spinal cord

Original Article

Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding

Original Article

Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors

Original Article

Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients

Letter to the Editor

Imaging studies in extramedullary hematopoiesis of the spleen
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits